Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
This is an open-label, single treatment study. All subjects will receive one year of oral
contraceptive therapy with DR-1011. Study participants will receive physical and
gynecological exams, including Pap smear. During the study, all participants will be required
to complete a diary.